Diabetes Mellitus, Type 2: all 9,590 studies
Page 26 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)CompletedNCT01296412Phase 3Results posted
- An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010CompletedNCT01294553Results posted
- Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT01294436Phase 3Results posted
- Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT01294423Phase 3Results posted
- Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesCompletedNCT01289990Phase 3Results posted
- Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesCompletedNCT01289119Phase 3Results posted
- Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 DiabetesCompletedNCT01285518Phase 1Results posted
- Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)CompletedNCT01285076Results posted
- A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic PatientsCompletedNCT01280695Phase 2Results posted
- Vinegar Co-ingestion in Type 2 DiabetesCompletedNCT01279317Not applicableResults posted
- Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)CompletedNCT01278485Results posted
- Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756CompletedNCT01278160Phase 4Results posted
- Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 DiabetesCompletedNCT01276288Phase 1Results posted
- Study of AC-201 in Patients With Type 2 Diabetes MellitusCompletedNCT01276106Phase 2Results posted
- Multiple Dose Study Of PF-04937319 In Patients With Type 2 DiabetesCompletedNCT01272804Phase 1Results posted
- Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT01272193Phase 3Results posted
- Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263509Phase 2/3Results posted
- Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedNCT01263496Phase 2Results posted
- Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263483Phase 2/3Results posted
- Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedNCT01263470Phase 2Results posted
- Colesevelam for Children With Type 2 DiabetesCompletedNCT01258075Phase 4Results posted
- Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity SurgeryCompletedNCT01257087Not applicableResults posted
- Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary AtherosclerosisCompletedNCT01254552Phase 4Results posted
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCompletedNCT01253304Phase 1Results posted
- A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy SubjectsCompletedNCT01248364Phase 2Results posted
- A Study of LY2608204 in Patients With Type 2 DiabetesCompletedNCT01247363Phase 1Results posted
- A Single Supplement of a Standardised Bilberry Extract Modifies Glycaemic ResponseCompletedNCT01245270Not applicableResults posted
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesCompletedNCT01243424Phase 3Results posted
- A Study of LY2409021 in Patients With Type 2 DiabetesCompletedNCT01241448Phase 2Results posted
- Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 DiabetesCompletedNCT01237301Not applicableResults posted
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)CompletedNCT01234649Phase 3Results posted
- Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCompletedNCT01232491Phase 4Results posted
- Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen NeedlesCompletedNCT01231984Not applicableResults posted
- A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes MellitusCompletedNCT01230749Phase 2Results posted
- Comparison of Efficacy of Vitamin D and Vitamin D-calcium Fortified Yogurt Drink in Diabetic PatientsCompletedNCT01229891Phase 2Results posted
- Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes MellitusCompletedNCT01226043Phase 4Results posted
- Effect of Pioglitazone on TIMP-3 and TACE in Type 2 DiabetesCompletedNCT01223196Phase 4Results posted
- Diabetes Self-Management Models to Reduce Health DisparitiesCompletedNCT01221090Phase 4Results posted
- Evaluation of Dapagliflozin Taken Twice-dailyCompletedNCT01217892Phase 3Results posted
- GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II DiabetesCompletedNCT01217112Phase 2Results posted
- A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)CompletedNCT01217073Phase 2Results posted
- A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCompletedNCT01215968Phase 1Results posted
- Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
- Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs AloneCompletedNCT01215435Phase 4Results posted
- Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin TherapyCompletedNCT01215097Phase 3Results posted
- Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic ControlCompletedNCT01214239Phase 3Results posted
- Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on BioavailabilityCompletedNCT01211197Phase 1Results posted
- Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With MetforminCompletedNCT01210001Phase 3Results posted
- Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 DiabetesCompletedNCT01206322Phase 2Results posted
- Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 DiabetesCompletedNCT01204775Phase 3Results posted
- Comprehensive Add on Study in JapanCompletedNCT01204294Phase 3Results posted
- Aspirin Dosing in Diabetic PatientsCompletedNCT01201785Phase 4Results posted
- Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 InhalerTerminatedNCT01196104Phase 3Results posted
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationCompletedNCT01195662Phase 3Results posted
- Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and SulfonylureaCompletedNCT01195090Phase 4Results posted
- Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-studyCompletedNCT01194830Phase 3Results posted
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusCompletedNCT01194258Phase 2Results posted
- Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01193218Phase 2Results posted
- Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes MellitusCompletedNCT01191320Phase 2Results posted
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)CompletedNCT01191268Phase 3Results posted
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)CompletedNCT01189890Phase 3Results posted
- START-J: SiTAgliptin in eldeRly Trial in JapanCompletedNCT01183104Not applicableResults posted
- 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 WeeksCompletedNCT01183013Phase 3Results posted
- OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump TherapyCompletedNCT01182493Not applicableResults posted
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and PrediabetesCompletedNCT01181986Phase 4Results posted
- Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedNCT01181674Phase 4Results posted
- Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsCompletedNCT01179048Phase 3Results posted
- Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01177813Phase 3Results posted
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)CompletedNCT01177384Phase 3Results posted
- Comparison of the Efficacy and Safety of Two Insulin Intensification StrategiesCompletedNCT01175824Phase 4Results posted
- A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusCompletedNCT01175811Phase 4Results posted
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 DiabetesCompletedNCT01175473Phase 2Results posted
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by MetforminCompletedNCT01169779Phase 3Results posted
- Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesCompletedNCT01167881Phase 3Results posted
- The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and DiabetesCompletedNCT01165983Not applicableResults posted
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedNCT01165684Phase 4Results posted
- Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentCompletedNCT01164501Phase 3Results posted
- Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic TherapyCompletedNCT01163721Phase 2Results posted
- A Study of Postprandial Hyperglycemia in Participants With Type 2 DiabetesCompletedNCT01159938Phase 4Results posted
- Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01159600Phase 3Results posted
- Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With DiabetesCompletedNCT01156597Phase 3Results posted
- Hypogonadism in Young Men With Type 2 DiabetesTerminatedNCT01155518Phase 2Results posted
- Exeantide in Type 2 Diabetes on InsulinCompletedNCT01154933Phase 2Results posted
- Diabetes and Gastric By- PassCompletedNCT01153516Results posted
- Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus PatientsCompletedNCT01152385Phase 2Results posted
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCompletedNCT01149421Phase 2Results posted
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01147627Not applicableResults posted
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusCompletedNCT01144338Phase 3Results posted
- Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 DiabetesCompletedNCT01142297Not applicableResults posted
- The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)CompletedNCT01137812Phase 3Results posted
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerCompletedNCT01137474Phase 3Results posted
- Impact of Exenatide on Sleep in Type 2 DiabetesCompletedNCT01136798Not applicableResults posted
- Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 DiabetesCompletedNCT01136785Not applicableResults posted
- Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)CompletedNCT01135992Phase 3Results posted
- Pharmacogenomics of ThiazolidinedionesCompletedNCT01135394Not applicableResults posted
- BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).CompletedNCT01131676Phase 3Results posted
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)CompletedNCT01131182Phase 4Results posted
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.CompletedNCT01128894Phase 3Results posted
- A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263CompletedNCT01128621Phase 2Results posted
- Saxagliptin Triple Oral TherapyCompletedNCT01128153Phase 3Results posted